DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,026 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,677,038 | +2.8% | 79,310 | -0.5% | 5.16% | +4.9% |
Q2 2023 | $19,136,838 | -4.8% | 79,737 | +0.0% | 4.93% | -10.9% |
Q1 2023 | $20,093,184 | -5.7% | 79,731 | -0.7% | 5.53% | -10.0% |
Q4 2022 | $21,311,943 | +0.6% | 80,295 | -2.1% | 6.14% | -6.9% |
Q3 2022 | $21,189,000 | +1.8% | 82,037 | -0.1% | 6.59% | +12.6% |
Q2 2022 | $20,813,000 | -13.9% | 82,096 | -0.4% | 5.85% | +3.3% |
Q1 2022 | $24,182,000 | -11.7% | 82,440 | -1.0% | 5.66% | -16.4% |
Q4 2021 | $27,398,000 | +7.8% | 83,275 | -0.2% | 6.78% | -1.9% |
Q3 2021 | $25,406,000 | +13.3% | 83,452 | -0.2% | 6.91% | +9.9% |
Q2 2021 | $22,430,000 | +18.3% | 83,584 | -0.8% | 6.29% | +6.1% |
Q1 2021 | $18,956,000 | +0.7% | 84,219 | -0.6% | 5.92% | -3.2% |
Q4 2020 | $18,830,000 | +2.7% | 84,768 | -0.5% | 6.12% | -9.0% |
Q3 2020 | $18,340,000 | +21.3% | 85,170 | -0.4% | 6.72% | +6.3% |
Q2 2020 | $15,125,000 | +26.9% | 85,532 | -0.7% | 6.32% | +5.2% |
Q1 2020 | $11,920,000 | -6.2% | 86,122 | +4.0% | 6.01% | +14.5% |
Q4 2019 | $12,711,000 | +5.6% | 82,817 | -0.6% | 5.25% | -2.2% |
Q3 2019 | $12,035,000 | 0.0% | 83,328 | -1.0% | 5.37% | -0.5% |
Q2 2019 | $12,035,000 | +7.8% | 84,209 | -0.4% | 5.40% | 0.0% |
Q1 2019 | $11,166,000 | +27.1% | 84,579 | -0.7% | 5.40% | +12.3% |
Q4 2018 | $8,786,000 | +1.5% | 85,206 | +7.0% | 4.80% | +12.1% |
Q3 2018 | $8,653,000 | +9.3% | 79,630 | +0.1% | 4.29% | +1.2% |
Q2 2018 | $7,916,000 | +9.8% | 79,559 | +8.0% | 4.24% | +8.6% |
Q1 2018 | $7,210,000 | +28.2% | 73,643 | +21.6% | 3.90% | +24.3% |
Q4 2017 | $5,623,000 | +115.1% | 60,581 | +98.8% | 3.14% | +94.5% |
Q3 2017 | $2,614,000 | -2.7% | 30,477 | -4.3% | 1.61% | -4.3% |
Q2 2017 | $2,686,000 | +37.6% | 31,834 | +39.5% | 1.69% | +27.8% |
Q1 2017 | $1,952,000 | +791.3% | 22,822 | +712.2% | 1.32% | +745.5% |
Q4 2016 | $219,000 | +6.3% | 2,810 | +7.2% | 0.16% | +2.6% |
Q3 2016 | $206,000 | -18.6% | 2,622 | +4.5% | 0.15% | -19.6% |
Q2 2016 | $253,000 | +6.8% | 2,508 | +0.3% | 0.19% | +6.2% |
Q1 2016 | $237,000 | +2.2% | 2,500 | 0.0% | 0.18% | -3.8% |
Q4 2015 | $232,000 | +8.9% | 2,500 | 0.0% | 0.18% | +4.5% |
Q3 2015 | $213,000 | -0.5% | 2,500 | 0.0% | 0.18% | -1.7% |
Q2 2015 | $214,000 | +0.9% | 2,500 | 0.0% | 0.18% | -1.1% |
Q1 2015 | $212,000 | -0.9% | 2,500 | 0.0% | 0.18% | -1.6% |
Q4 2014 | $214,000 | – | 2,500 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |